To the top

Page Manager: Webmaster
Last update: 9/11/2012 3:13 PM

Tell a friend about this page
Print version

Immunopathogenesis of inf… - University of Gothenburg, Sweden Till startsida
To content Read more about how we use cookies on

Immunopathogenesis of inflammatory bowel disease and mechanisms of biological therapies

Journal article
Authors Bani Ahluwalia
Luiza Moraes
Maria K Magnusson
Lena Öhman
Published in Scandinavian Journal of Gastroenterology
Volume 53
Issue 4
Pages 379-389
ISSN 0036-5521
Publication year 2018
Published at Institute of Biomedicine, Department of Microbiology and Immunology
Institute of Medicine, Department of Internal Medicine and Clinical Nutrition
Pages 379-389
Language en
Keywords IBD, immunopathogenesis, Crohn's disease, ulcerative colitis, chronic inflammation, dysregulated, innate lymphoid-cells, severe crohns-disease, placebo-controlled trial, regulatory t-cell, intestinal epithelial-cells, toll-like receptor-9, anti-tnf therapy, ulcerative-colitis, dendritic cells, maintenance, therapy, Gastroenterology & Hepatology
Subject categories Gastroenterology and Hepatology


Inflammatory bowel disease (IBD) is a chronic inflammatory disorder of the gastrointestinal tract with a multifactorial pathophysiology. Full comprehension of IBD pathology is still out of reach and, therefore, treatment is far from ideal. Nevertheless, components involved in IBD pathogenesis including environmental, genetic, microbial, and immunological factors are continuously being investigated and the improved knowledge contributes to the development of new therapies. In this article we review the aspects of the immunopathogenesis of IBD, with focus on mucosal immunity, and discuss mechanisms of action for current and emerging biological therapies.

Page Manager: Webmaster|Last update: 9/11/2012

The University of Gothenburg uses cookies to provide you with the best possible user experience. By continuing on this website, you approve of our use of cookies.  What are cookies?